SCHEMBL29566872

SCHEMBL29566872

Cc1ccccc1Oc1cc(C2C(C)(C)C2(C)C)nc(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 2/20 0.46
▸ KMT2A Q03164 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MAP4K4 O95819 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.36
▸ AKT1 P31749 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ DHFR P00374 1/20 0.34
▸ BCHE P06276 2/20 0.34
▸ ACHE P22303 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566989 0.77 NUDT1 (0.43) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24310321 0.77 NUDT1 (0.43) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24309816 0.77 NUDT1 (0.43) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24309324 0.77 NUDT1 (0.47) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24309720 0.70 NUDT1 (0.43) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL29567237 0.70 NUDT1 (0.43) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL17623909 0.65 MEN1 (0.56) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24309817 0.65 NUDT1 (0.41) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL4535033 0.65 HSP90AA1 (0.51) NUDT1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL24309982 0.65 HSP90AB1 (0.42) KMT2AMEN1CYP1A2CYP2C19HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback